Blumenthal, D. “Employer-Sponsored Health Insurance in the United States—Origins and Implications.” New England Journal of Medicine 35, no. 1 (2006): 82–88. doi: 10.1056/NEJMhpr060703.
Centers for Medicare & Medicaid Services. National Health Expenditures 2017 Highlights. Department of Health and Human Services, 2018. www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/highlights.pdf.
Emanuel, Ezekiel J. Prescription for the Future: The Twelve Transformational Practices of Highly Effective Medical Organizations. New York: PublicAffairs, 2017.
Rice, T., P. Rosenau, L. Y. Unruh, A. J. Barnes, R. B. Saltman, and E. van Ginneken. “United States of America: Health System Review.” Health Systems in Transition 15, no. 3 (2013): 1–431.
Starr, P. The Social Transformation of American Medicine: The Rise of a Sovereign Profession and the Making of a Vast Industry. New York: Basic Books, 2017.
The Commonwealth Fund. “The U.S. Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 173–181. The Commonwealth Fund, 2017.
Vignette Adapted From
Hearing on “No More Surprises: Protecting Patients from Surprise Medical Bills.” 2123 Rayburn House Office Building: House Committee on Energy and Commerce, 2019. https://energycommerce.house.gov/committee-activity/hearings/hearing-on-no-more-surprises-protecting-patients-from-surprise-medical.
Brandt, J., B. Shearer, and S. G. Morgan. “Prescription Drug Coverage in Canada: A Review of the Economic, Policy and Political Considerations for Universal Pharmacare.” Journal of Pharmaceutical Policy and Practice 11, no. 1 (2018): 1–13. doi: 10.1186/s40545-018-0154-x.
Canadian Institute for Health Information. National Health Expenditure Trends, 1975 to 2018. Ottawa, ON: CIHI, 2019. www.cihi.ca/en/health-spending/2018/national-health-expenditure-trends.
Canadian Institute for Health Information. Physicians in Canada, 2016: Summary Report. Ottawa, ON: CIHI, 2017. https://secure.cihi.ca/free_products/Physicians_in_Canada_2016.pdf.
Allin, S. and D. Rudoler. “The Canadian Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 21–30. The Commonwealth Fund, 2017.
Marchildon, G. P. “Canada: Health System Review.” Health Systems in Transition 15, no. 1 (2013): 1–79.
Morgan, S. G. and K. Boothe. “Universal Prescription Drug Coverage in Canada: Long-Promised yet Undelivered.” Health Management Forum 29, no. 6 (2016): 247–254.
Santé, MdSedl. “Les dépenses de santé en 2016—Résultats des comptes de la santé—édition 2017.” 2017. http://drees.solidarites-sante.gouv.fr/IMG/pdf/cns_2017.pdf.
Seroussi, B. and J. Bouaud. “Adoption of a Nationwide Shared Medical Record in France: Lessons Learnt After 5 Years of Deployment.” AMIA Annual Symposium Proceedings (2016): 1100–1109.
Stone, C. P. “A Glimpse at EHR Implementation Around the World: The Lessons the US Can Learn.” The Health Institute for E-Health Policy, 2014. www.e-healthpolicy.org/docs/A_Glimpse_at_EHR_Implementation_Around_the_World1_ChrisStone.pdf.
Vignette Adapted and Quoted From
Kassam A. “The Serious Flaw in Canada’s Healthcare System: Prescription Drugs Aren’t Free.” The Guardian, October 20, 2017. www.theguardian.com/world/2017/oct/20/canada-national-pharmacare-prescription-drugs.
British Medical Association. “General Practice in the UK—Background Briefing.” April 2017.
Cylus, J., E. Richardson, L. Findley, M. Longley, C. O’Neill, and D. Steel. “United Kingdom: Health System Review.” Health Systems in Transition 17, no. 5 (2015): 1–125.
Department of Health and Social Care. The 2019 Voluntary Scheme for Branded Medicines Pricing and Access: Chapters and Glossary. GOV.UK, 2018. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/761834/voluntary-scheme-for-branded-medicines-pricing-and-access-chapters-and-glossary.pdf.
Gershlick, B. Best Practice Tariffs: United Kingdom (England). The Health Foundation, 2016. www.oecd.org/els/health-systems/Better-Ways-to-Pay-for-Health-Care-Background-Note-England-Best-practice-tariffs.pdf.
Milne, C. “Mental Health Spending in the English NHS: Full Fact.” May 17, 2019. https://fullfact.org/health/mental-health-spending-england/.
Office for National Statistics. Healthcare Expenditure, UK Health Accounts: 2017. Office for National Statistics, 2019. www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem/bulletins/ukhealthaccounts/2017.
Robertson, R., J. Appleby, H. Evans, and N. Hemmings. Public Satisfaction with the NHS and Social Care in 2018, 2019. www.kingsfund.org.uk/publications/public-satisfaction-nhs-social-care-2018.
Thorlby, R. and S. Arora. “The English Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, D. Sarnak, 49–58. The Commonwealth Fund, 2017.
Vignette Adapted and Quoted From
Central Office of Information for the Ministry of Health. The New National Health Service, February 1948.
Apotekforeningen. “Key Figures 2017: Pharmacies and Pharmaceuticals in Norway.” 2018. www.apotek.no/Files/Filer_2014/Engelske_sider/Pharmacies%20and%20prescriptions%20-%20%20Key%20Figures%202017.pdf.
Brekke, K. R., T. H. Holmås, and O. R. Straume. Are Pharmaceuticals Still Inexpensive in Norway?: A Comparison of Prescription Drug Prices in Ten European Countries. Bergen: SNF, 2010. https://openaccess.nhh.no/nhh-xmlui/handle/11250/165071.
Ernst & Young Global Limited. The Norwegian Processes for Implementation of Medicinal Products and the Associated Tenders: Specialist Health Services. EYGM Limited. 2019. www.ey.com/Publication/vwLUAssets/Er_anbud_alltid_losningen_for_legemidler/$FILE/B18022no-Implementation-Medical%20products_07LR_final.pdf.
European Monitoring Centre for Drugs and Drug Addiction. “Norway, Country Drug Report 2019.” www.emcdda.europa.eu/publications/country-drug-reports/2019/norway_en. Published June 2019.
Johansen, I. H., T. Morken, and S. Hunskaar. “How Norwegian Casualty Clinics Handle Contacts Related to Mental Illness: A Prospective Observational Study.” International Journal of Mental Health Systems 6, no. 1 (2012): 3. doi: 10.1186/1752-4458-6-3.
Lindahl, A. K. “The Norwegian Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 129–138. The Commonwealth Fund, 2017.
Ministry of Health and Care Services. The Primary Health and Care Services of Tomorrow—Localised and Integrated. Norwegian Ministry of Health and Care Services, 2015. www.regjeringen.no/en/dokumenter/meld.-st.-26-20142015/id2409890/.
Ringard, Å., A. Sagan, I. Sperre Saunes, and A. K. Lindahl. “Norway: Health System Review.” Health Systems in Transition 15, no. 8 (2013): 1–162.
Statistics Norway. “Earnings.” Statbank, 2019. www.ssb.no/en/arbeid-og-lonn/statistikker/lonnansatt.
Steihaug, S., B. Paulsen, and L. Melby. “Norwegian General Practitioners’ Collaboration with Municipal Care Providers—A Qualitative Study of Structural Conditions.” Scandinavian Journal of Primary Health Care 35, no. 4 (2017): 344–351. doi: 10.1080/02813432.2017.1397264.
Vignette Adapted and Quoted From
Brune, V. “What Happens When You Get Sick in Norway // My Story & All You Need to Know.” Nordic Wanders, May 9, 2018. https://nordicwanders.com/blog/2018/05/experience-norwegian-healthcare-system.
Chevreul, K., K. B. Brigham, I. Durand-Zaleski, and C. Hernández-Quevedo. “France: Health System Review.” Health Systems in Transition, 2015. www.euro.who.int/__data/assets/pdf_file/0011/297938/France-HiT.pdf.
Durand-Zaleski, I. “The French Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 59–68. The Commonwealth Fund, 2017.
Dutton, P. Differential Diagnoses: A Comparative History of Health Care Problems and Solutions in the United States and France. Ithaca, NY: ILR Press, 2007.
Rodwin, V. G. “The Health Care System Under French National Health Insurance: Lessons for Health Reform in the United States.” American Journal of Public Health 93, no. 1 (2003): 31–37.
Seroussi, B. and J. Bouaud. “Adoption of a Nationwide Shared Medical Record in France: Lessons Learnt after 5 Years of Deployment.” AMIA Annual Symposium Proceedings, 2016: 1100–1109.
Stone, C. P. “A Glimpse at EHR Implementation Around the World: The Lessons the US Can Learn.” The Health Institute for E-Health Policy, 2014. www.e-healthpolicy.org/docs/A_Glimpse_at_EHR_Implementation_Around_the_World1_ChrisStone.pdf.
Vignette Adapted From
The World Health Report 2000: Health Systems: Improving Performance. Geneva: WHO, 2000. www.who.int/whr/2000/en/whr00_en.pdf?ua=1.
Blümel, M. and R. Busse. “The German Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 69–76. The Commonwealth Fund, 2017.
Busse, R. and M. Blümel. “Germany: Health System Review.” Health Systems in Transition 16, no. 2 (2014): 1–296.
Busse, R., M. Blümel, F. Knieps, and T. Bärnighausen. “Statutory Health Insurance in Germany: A Health System Shaped by 135 Years of Solidarity, Self-Governance, and Competition.” The Lancet 390, no. 10097 (2017): 882–897. doi: 10.1016/S0140-6736(17)31280-1.
European Commission. Germany: Country Health Profile 2017. OECD, 2017. www.oecd.org/publications/germany-country-health-profile-2017-9789264283398-en.htm.
Statistisches Bundesamt. “Health Expenditure.” Destatis, 2019. www.destatis.de/EN/Themes/Society-Environment/Health/Health-Expenditure/_node.html.
Alders, P. and F. T. Schut. “The 2015 Long-Term Care Reform in the Netherlands: Getting the Financial Incentives Right?” Health Policy 123, no. 3 (2019): 312–316. doi: 10.1016/j.healthpol.2018.10.010.
CBS Netherlands. “Health Expenditure: Functions and Financing for International Comparisons.” June 21, 2019. https://opendata.cbs.nl/statline/#/CBS/en/dataset/84043ENG/table?ts=1548188388918.
de Graaff, R. and I. Spee. Current Developments in the Dutch Healthcare Market: 2018. Seijgraaf Consultancy B.V., 2018. www.welfaretech.dk/media/6800/current-developments-in-the-dutch-healthcare-market.pdf.
Government of the Netherlands. Ministry of Health, Welfare, and Sport, 2019. www.government.nl/ministries/ministry-of-health-welfare-and-sport.
Government of the Netherlands. Zorginstituut Nederland, 2019. www.zorginstituutnederland.nl/.
Hendriks, R. H. M., K. F. E. Veraghtert, B. E. M. Widdershoven, and K. P. Companje. Two Centuries of Solidarity: German, Belgian and Dutch Social Health Insurance 1770–2008. Amsterdam: Aksant Academic Publishers, 2009. doi: 10.26530/OAPEN_353800.
Kroneman, M., W. Boerma, M. van den Berg, P. Groenewegen, J. de Jong, and E. van Ginneken. “The Netherlands: Health System Review.” Health Systems in Transition 1, no. 2 (2016): 1–239.
Organisation for Economic Co-operation and Development. “Health Expenditure and Financing.” OECD.Stat, 2019. https://stats.oecd.org.
Smits, M., M. Rutten, E. Keizer, M. Wensing, G. Westert, and P. Giesen. “The Development and Performance of After-Hours Primary Care in the Netherlands: A Narrative Review.” Annals of Internal Medicine 166, no. 10 (2017): 737–742. doi: 10.7326/M16-2776.
van Loenen, T., M. J. van den Berg, S. Heinemann, R. Baker, M. J. Faber, and G. P. Westert. “Trends Towards Stronger Primary Care in Three Western European Countries: 2006–2012.” BMC Family Practice 17, no. 1 (2016): 59. doi: 10.1186/s12875-016-0458-3.
Wammes, J., P. Jeurissen, G. Westert, and M. Tanke. “The Dutch Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 113–120. The Commonwealth Fund, 2017.
Vignette Adapted and Quoted From
Avery, L. “Healthcare in the Netherlands: Is It Really That Good?” DutchReview, November 2016. https://dutchreview.com/expat/health/healthcare-in-the-netherlands-2/.
Commonwealth Fund. “Generic Drugs Often Cost Double in Switzerland.” Commonwealth Fund International Health News Brief, April 19, 2018. www.commonwealthfund.org/publications/newsletter-article/2018/apr/generic-drugs-often-cost-double-switzerland.
De Pietro, C., P. Camenzind, I. SturnyI, L. Crivelli, S. Edwards-Garavoglia, A. Spranger, F. Wittenbecher, and W. Quentin. “Switzerland: Health System Review.” Health Systems in Transition 17, no. 4 (2015): 1–288.
Interpharma. “Swiss Healthcare and Pharmaceutical Market: Pharmacies Remain the Most Important Sales Outlet.” Interpharma. www.interpharma.ch/fakten-statistiken/4460-pharmacies-remain-most-important-sales-outlet.
Sturny, I. “The Swiss Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 155–162. The Commonwealth Fund, 2017.
Swiss Confederation. Health Equity: Facts and Figures for Switzerland. Federal Office of Public Health, 2018. www.bag.admin.ch/bag/en/home/zahlen-und-statistiken/zahlen-fakten-zu-chancengleichheit.html.
Swiss Confederation. Statistics of Medical Professions 2017. Federal Office of Public Health, 2018. www.bag.admin.ch/bag/en/home/zahlen-und-statistiken/statistiken-berufe-im-gesundheitswesen.html.
Aged Care Financing Authority. “Aged Care Financing Authority Annual Reports.” Australian Government Department of Health, August 10, 2019. https://agedcare.health.gov.au/reform/aged-care-financing-authority/aged-care-financing-authority-annual-reports.
Australian Institute for Health and Welfare. “Reports & Data.” Australian Institute of Health and Welfare. www.aihw.gov.au/reports-data.
Boxall, A.-M. and J. A. Gillespie. Making Medicare: The Politics of Universal Health Care in Australia. Sydney: NewSouth Publishing, 2013.
Duckett, S. J. and S. Wilcox. The Australian Health Care System. 5th ed. South Melbourne, Victoria, Australia: Oxford University Press, 2015.
GlaxoSmithKline Australia Pty Ltd and ViiV Healthcare Pty Ltd. The Pharmaceutical Benefits Scheme in Australia: An Explainer on System Components, 2018. https://au.gsk.com/media/421635/gsk-viiv-the-pbs-in-australia-feb-2018.pdf.
Glover, L. “The Australian Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 11–20. The Commonwealth Fund, 2017.
Goddard, M. S. “How the Pharmaceutical Benefits Scheme Began.” Medical Journal of Australia 201, no. 1 (2014): S23–S25. doi: 10.5694/mja14.00124.
Healy, J., E. Sharman, and B. Lokuge. “Australia: Health System Review.” Health Systems in Transition 8, no. 5 (2006): 1–158.
Vignette Adapted and Quoted From
Aubusson, K. “AMA Name-Dropped on ‘Egregious’ $18,000 Sydney Surgeon Bill.” Sydney Morning Herald, June 3, 2018. www.smh.com.au/healthcare/ama-name-dropped-on-egregious-18-000-sydney-surgeon-bill-20180601-p4ziy8.html.
Duckett, S. “Australia’s Health System Is Enviable, but There’s Room for Improvement.” The Conversation, September 21, 2017. http://theconversation.com/australias-health-system-is-enviable-but-theres-room-for-improvement-81332.
Victoria State Government Department of Health and Human Services. “Hospital Costs and Payments.” Better Health Channel, September 2015. www.betterhealth.vic.gov.au:443/health/servicesandsupport/hospital-costs-and-payments.
Cohn, J. “If You Don’t Believe Single Payer Can Work, See How They Do It in Taiwan.” HuffPost, September 8, 2018. www.huffpost.com/entry/single-payer-medicare-taiwan_n_5b9295ede4b0511db3e1d45a.
Cheng, T.-M. “The Taiwanese Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, and D. Sarnak, 163–172. The Commonwealth Fund, 2017.
Hsiao, W. C., S.-H. Cheng, and W. Yip. “What Can Be Achieved with a Single-Payer NHI System: The Case of Taiwan.” Social Science & Medicine 233 (2019): 265–271. doi: 10.1016/j.socscimed.2016.12.006.
Reinhardt, U. E. “Humbled in Taiwan.” BMJ 336, no. 7635 (2008): 72. doi: 10.1136/bmj.39450.473380.0F.
Palfreman, J. Sick Around the World. Frontline, 2008. www.pbs.org/wgbh/pages/frontline/sickaroundtheworld.
Ministry of Health and Welfare. 2018 Taiwan Health and Welfare Report. Taipei, Taiwan: Ministry of Health and Welfare, 2018. www.cdway.com.tw/gov/mhw2/book107/book1e/#p=22.
National Health Insurance Administration. “2017–2018 National Health Insurance Annual Report.” Taiwan Ministry of Health and Welfare, 2018. www.nhi.gov.tw/english/Content_List.aspx?n=8FC0974BBFEFA56D&topn=ED4A30E51A609E49.
Price Waterhouse Cooper. “Taiwan Health Industries: An Introductory Market Overview.” 2018. www.pwc.tw/en/publications/assets/taiwan-health-industries.pdf.
Yeh, M.-J. “Long-Term Care System in Taiwan: The 2017 Major Reform and Its Challenges.” Ageing & Society (January 2019): 1–18. doi: 10.1017/S0144686X18001745.
Vignette Adapted and Quoted From
Cohn, J. “If You Don’t Believe Single Payer Can Work, See How They Do It in Taiwan.” HuffPost, September 8, 2018. www.huffpost.com/entry/single-payer-medicare-taiwan_n_5b9295ede4b0511db3e1d45a.
Blumenthal, D. and W. Hsiao. “Privatization and Its Discontents—The Evolving Chinese Health Care System.” New England Journal of Medicine 353, no. 11 (2015). doi: 10.1056/NEJMhpr051133.
Burns, L. R. and G. G. Liu. China’s Healthcare System and Reform (Cambridge: Cambridge University Press, 2017).
Fang, H. “The Chinese Health Care System.” In International Profiles of Health Care Systems, edited by E. Mossialos, A. Djordjevic, R. Osborn, D. Sarnak, 31–38. The Commonwealth Fund, 2017.
Hu, D., W. Zhu, Y. Fu, M. Zhang, Y. Zhao, K. Hanson, M. Martinez-Alvarez, and X. Liu. “Development of Village Doctors in China: Financial Compensation and Health System Support.” International Journal of Equity Health 16 (2017). doi: 10.1186/s12939-016-0505-7.
Huang, F. and L. Gan. “The Impacts of China’s Urban Employee Basic Medical Insurance on Healthcare Expenditures and Health Outcomes.” Health Economics 26, no. 2 (2017): 149–163. doi: 10.1002/hec.3281.
Li, X., J. Lu, S. Hu, K. K. Cheng, J. De Maeseneer, E. Mossialos, D. R. Xu, et al. “The Primary Health-Care System in China.” The Lancet 390, no. 10112 (2017): 2584–2594. doi: 10.1016/S0140-6736(17)33109-4.
Liu, X. and H. Cao. “China’s Cooperative Medical System: Its Historical Transformations and the Trend of Development.” Journal of Public Health Policy 13, no. 4 (1992): 501–511.
Luo, Y., W. Bossany, J. Wong, and C. Chen. “Opportunities Open Up in Chinese Private Health Insurance.” Boston Consulting Group, August 24, 2016. www.bcg.com/publications/2016/insurance-health-care-payers-providers-opportunities-open-up-in-chinese-private-health-insurance.aspx.
Ma, J., M. Lu, and H. Quan. “From a National, Centrally Planned Health System to a System Based on the Market: Lessons from China.” Health Affairs 27, no. 4 (2018): 937–948. doi: 10.1377/hlthaff.27.4.937.
Mossialos, E., Y. Ge, J. Hu, and W. Liejun. Pharmaceutical Policy in China: Challenges and Opportunities for Reform. Copenhagen, Denmark: WHO Regional Office for Europe, 2016. www.euro.who.int/__data/assets/pdf_file/0020/320465/Pharmaceutical-policy-China-challenges-opportunities-reform.pdf?ua=1.
National Bureau of Statistics of China. China Statistical Yearbook 2017. China Statistics Press, 2017. www.stats.gov.cn/tjsj/ndsj/2017/indexeh.htm.
National Bureau of Statistics of China. China Statistical Yearbook 2018. China Statistics Press, 2018. www.stats.gov.cn/tjsj/ndsj/2018/indexeh.htm.
OECD. “OECD Health Statistics 2014: How Does China Compare?” 2014. www.oecd.org/els/health-systems/Briefing-Note-CHINA-2014.pdf.
Pu, X., Y. Gu, and X. Wang. “Provider Payment to Primary Care Physicians in China: Background, Challenges, and a Reform Framework.” Primary Health Care Research and Development 20 (2018). doi: 10.1017/S146342361800021X.
Que, J., L. Lu, and L. Shi. “Development and Challenges of Mental Health in China.” General Psychology 32, no. 1 (2019): e100053. doi: 10.1136/gpsych-2019-100053.
Ren, X., J. Yin, B. Wang, and M. R. Schwarz. “A Descriptive Analysis of Medical Education in China.” Medical Teacher 30, no. 7 (2008): 667–672. doi: 10.1080/01421590802155100.
Wang, Q., Y. Zhou, X. Ding, and X. Ying. “Demand for Long-Term Care Insurance in China.” International Journal of Environmental Research and Public Health 15, no. 1 (2018). doi: 10.3390/ijerph15010006.
Yang, L., L. Sun, L. Wen, H. Zhang, C. Li, K. Hanson, and H. Fang. “Financing Strategies to Improve Essential Public Health Equalization and Its Effects in China.” International Journal of Equity in Health 15 (2016). doi: 10.1186/s12939-016-0482-x.
Zhu, K., L. Zhang, S. Yuan, X. Zhang, and Z. Zhang. “Health Financing and Integration of Urban and Rural Residents’ Basic Medical Insurance Systems in China.” International Journal for Equity in Health 16, no. 1 (2017).
Vignette Adapted and Quoted From
Nie, J.-B., Y. Cheng, X. Zou, N. Gong, J. D. Tucker, B. Wong, and A. Kleinman. “The Vicious Circle of Patient-Physician Mistrust in China: Health Professionals’ Perspectives, Institutional Conflict of Interest, and Building Trust Through Medical Professionalism.” Developing World Bioethics 18, no. 1 (2018): 26–36. doi: 10.1111/dewb.12170.